Pancreatic Cancer Research

ResearcherUniversity of VeronaActive in the last 2 years

Alberto Balduzzi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6018-8816; OpenAlex author ID A5077928414. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
73
Papers, trials and grants by year

2019: 1 paper · 2020: 3 papers · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 2 papers · 2026: 1 paper

Papers 9

  1. The European Multidisciplinary Evidence-Based Guideline on Pancreatic Cancer: Methodological Protocol. Co-author DOI 10.1002/gin2.70074↗
  2. Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX. Co-author DOI 10.1001/jamaoncol.2024.5917↗
  3. Validation of the PANAMA Score for Survival and Benefit of Adjuvant Therapy in Patients With Resected Pancreatic Cancer after Neoadjuvant FOLFIRINOX. Co-author DOI 10.1097/sla.0000000000006650↗
  4. Surgical and Oncological Outcomes After Preoperative FOLFIRINOX Chemotherapy in Resected Pancreatic Cancer: An International Multicenter Cohort Study. Co-author DOI 10.1245/s10434-022-12387-2↗
  5. Laparoscopic versus open extended radical left pancreatectomy for pancreatic ductal adenocarcinoma: an international propensity-score matched study. Co-author DOI 10.1007/s00464-020-08206-y↗
  6. Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment. Co-author DOI 10.1001/jamaoncol.2020.3537↗
  7. Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/ijc.32586↗
  8. Laparoscopic Radical Left Pancreatectomy for Pancreatic Cancer: Surgical Strategy and Technique Video. Co-author DOI 10.3791/60332↗
  9. Minimally invasive surgery for pancreatic cancer. First author DOI 10.1080/14737140.2019.1685878↗

Closest collaborators

The 25 strongest of 73 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Marc G. Besselink · 5 shared papers, 2020–2025 · strength 0.51
  2. Roberto Salvia · 4 shared papers, 2019–2025 · strength 0.41
  3. Tobias Keck · 3 shared papers, 2020–2025 · strength 0.31
  4. Adnan A. Alseidi · 3 shared papers, 2020–2025 · strength 0.31
  5. Frederik Christiaan Berrevoet · 3 shared papers, 2020–2025 · strength 0.31
  6. Thilo Hackert · 3 shared papers, 2020–2025 · strength 0.31
  7. Giovanni Butturini · 3 shared papers, 2020–2025 · strength 0.31
  8. Bas Groot Koerkamp · 3 shared papers, 2020–2025 · strength 0.31
  9. António Sá Cunha · 3 shared papers, 2020–2025 · strength 0.31
  10. Massimo Falconi · 3 shared papers, 2020–2025 · strength 0.31
  11. Hanneke W.M. van Laarhoven · 3 shared papers, 2020–2025 · strength 0.30
  12. Mohammad Abu Hilal · 3 shared papers, 2020–2021 · strength 0.28
  13. Morgan Bonds · 2 shared papers, 2020–2025 · strength 0.22
  14. Giuseppe Malleo · 2 shared papers, 2020–2025 · strength 0.22
  15. Asif Halimi · 2 shared papers, 2020–2025 · strength 0.22
  16. Daniel Pietrasz · 2 shared papers, 2020–2025 · strength 0.22
  17. Johan Gagnière · 2 shared papers, 2020–2025 · strength 0.22
  18. Stijn R. van Roessel · 2 shared papers, 2020–2025 · strength 0.22
  19. Kevin C. Conlon · 2 shared papers, 2020–2025 · strength 0.22
  20. Eran van Veldhuisen · 2 shared papers, 2020–2025 · strength 0.22
  21. Isabella M. Frigerio · 2 shared papers, 2020–2025 · strength 0.22
  22. Quisette P. Janssen · 2 shared papers, 2020–2025 · strength 0.22
  23. Keith John Roberts · 2 shared papers, 2020–2025 · strength 0.22
  24. Oonagh M. Griffin · 2 shared papers, 2020–2025 · strength 0.22
  25. Rupaly Pandé · 2 shared papers, 2020–2025 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.